Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research

User menu

  • My alerts

Search

  • Advanced search
Life Science Alliance
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research
  • My alerts
Life Science Alliance

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Follow lsa Template on Twitter
Research Article
Source Data
Transparent Process
Open Access

Caspase-1 cleaves Bid to release mitochondrial SMAC and drive secondary necrosis in the absence of GSDMD

Rosalie Heilig, Marisa Dilucca, View ORCID ProfileDave Boucher, View ORCID ProfileKaiwen W Chen, Dora Hancz, View ORCID ProfileBenjamin Demarco, Kateryna Shkarina, View ORCID ProfilePetr Broz  Correspondence email
Rosalie Heilig
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marisa Dilucca
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dave Boucher
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dave Boucher
Kaiwen W Chen
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kaiwen W Chen
Dora Hancz
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Demarco
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Benjamin Demarco
Kateryna Shkarina
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petr Broz
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Petr Broz
  • For correspondence: petr.broz@unil.ch
Published 28 April 2020. DOI: 10.26508/lsa.202000735
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF
Loading

Article Figures & Data

Figures

  • Figure S1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S1.

    Canonical and non-canonical inflammasome activation in Gsdmd−/− cells. (A, B) LDH release from LPS-primed WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− iBMDMs after transfection of LPS (A) or infection with log-phase S. typhimurium, treatment with Nigericin, or infection with F. novicida (B). (C) PI influx from mock or poly(dA:dT)–transfected LPS-primed Gsdmd−/− iBMDMs and LDH release from mock or poly(dA:dT) transfected LPS-primed WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− iBMDMs. (D) Immunoblots showing IL-1β, caspase-1, and GSDMD processing in WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− BMDMs after transfection of poly(dA:dT). Data and blot are representative of at least three independent experiments.

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. Canonical inflammasome activation Gsdmd-deficient macrophages results in rapid secondary necrosis.

    (A, B) LDH release, PI influx, and IL-1β release from LPS-primed WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary or immortalized BMDMs (BMDMs and iBMDMs) after transfection of poly(dA:dT) in the absence or presence of the indicated inhibitors. (C, D, E) DNA cleavage, PI influx, and immunoblots showing caspase-3/-7 processing from LPS-primed Gsdmd−/− BMDMs transfected with poly(dA:dT) or treated with 100 ng/ml TNF-α plus 10, 5, or 1 μM AZD5582 (extrinsic apoptosis) or 1 μM ABT-737 plus 10, 1, or 0.5 μM S63845 (intrinsic apoptosis). (F) Confocal images of LPS-primed Gsdmd−/− BMDMs transfected with poly(dA:dT) or left untreated and stained with CellTox Green (green). Scale bar = 10 μM. Graphs show mean ± SD. Data and blot are representative of at least three independent experiments.

  • Figure S2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S2. Effect of inhibitor treatment on cell death in Gsdmd−/− cells.

    PI influx from poly(dA:dT)–transfected LPS-primed Gsdmd−/− iBMDMs in the presence or absence of the indicated inhibitors added to the cells 30 min prior and during the experiment at the following concentrations: 50, 25, 12.5, and 6.25 μM VX765; 100, 50, 25, and 12.5 μM Caspase-3/7–specific inhibitor I; 30, 15, 7.5, and 3.25 μM K777; 100, 50, 25, and 12.5 μM PD 150606; 100, 50, 25, and 12.5 μM Calpeptin; 60, 30, 15, and 7.5 μM 7-Cl-O-Nec1; and 100, 50, 25, and 12.5 μM GSK872. Data and blot are representative of at least three independent experiments.

  • Figure S3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S3.

    AIM2 activation in Gsdmd−/− results in rapid lytic cell death. (A, B) Confocal microscopy images of poly(dA:dT) (A) or mock transfected (B) WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary BMDMs. Cells were stained with CellTox Green (green) and AnnexinV (red). (A, C) Selected cells from (A). Scale bar = 10 μm.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. Caspase-3 drives GSDMD-independent secondary necrosis in inflammasome activated cells.

    (A, B) LDH release, caspase-3/-7 activity (DEVDase activity) and immunoblots showing caspase-3/-7 processing from LPS-primed WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary BMDMs after transfection of poly(dA:dT). (C) LDH release from LPS-primed WT, Asc−/−, Casp1−/−/Casp11−/−, Gsdmd−/−, Gsdmd−/−/Casp3−/−, Gsdmd−/−/Casp7−/−, and Gsdmd−/−/Casp3−/−/Casp7−/− iBMDMs after transfection of poly(dA:dT). (C, D) Confocal images of cells from (C). Insets show membrane ballooning in dying cells at 3 h post-transfection. Scale bar = 10 μm. (E) Quantification of LDH release in LPS primed WT, Asc−/−, Casp-1−/−/Casp-11−/−, Gsdmd−/−, Gsdme−/−, and Gsdmd−/−/Gsdme−/− BMDMs transfected with poly(dA:dT) for 4 h. Graphs show mean ± SD. **P ≤ 0.01, ***P ≤ 0.001, “ns,” no significance (unpaired t test). Data and blot are representative of at least three independent experiments.

  • Figure S4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S4.

    Caspase-3 but not caspase-7 is required for lysis in Gsdmd−/− cells. (A) LDH release and caspase-3/-7 activity (DEVDase activity) from LPS-primed WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary BMDMs after transfection of Salmonella typhimurium at MOI 10. (B) Immunoblots for caspase-3 and caspase-7 expression in lysates of Gsdmd−/−, Gsdmd−/−/Casp3−/−, Gsdmd−/−/Casp7−/−, and Gsdmd−/−/Casp3−/−/Casp7−/− iBMDMs. (C) PI influx from LPS-primed WT, Asc−/−, Casp1−/−/Casp11−/−, Gsdmd−/−, pool of Gsdmd−/−/Casp3−/− clones (n = 3), pool of Gsdmd−/−/Casp7−/− clones (n = 5), and Gsdmd−/−/Casp3−/−/Casp7−/− iBMDMs after transfection of poly(dA:dT). (D) Immunoblots showing caspase-3, caspase-7, and caspase-8 expression and LDH release after transfection poly(dA:dT) transfection from LPS-primed Gsdmd−/− iBMDMs transfected with control siRNA or siRNA targeting caspase-3, caspase-7, caspase-8 or both caspase-3/-7. Graphs show mean ± SD. **P ≤ 0.01, ***P ≤ 0.001 (unpaired t test). Data and blot are representative of at least three independent experiments.

    Source data are available for this figure.

    Source Data for Figure S4[LSA-2020-00735_SdataFS4.pdf]

  • Figure S5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S5.

    GSDME is not required for GSDMD-independent secondary necrosis. (A) Quantification of PI uptake in LPS primed WT, Asc−/−, Casp-1−/−/Casp-11−/−, Gsdmd−/−, Gsdme−/−, and Gsdmd−/−/Gsdme−/− BMDMs transfected with poly(dA:dT) for 4 h. (B) Immunoblot for GSDMD, GSDME, caspase-1, and tubulin on pooled supernatant and lysate samples collected at indicated times. Graph shows mean ± SD. Graph and blot are representative of at least three independent experiments.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. Caspase-1 is required for GSDMD-independent secondary necrosis.

    (A, B, C) Immunoblot showing Caspase-1 expression and caspase-3 processing, LDH release, and caspase-3/-7 activity (DEVDase activity) from LPS-primed Gsdmd−/− and Gsdmd−/−/Casp1−/− immortalized BMDMs after transfection of poly(dA:dT). (D) PI influx of WT, Asc−/−, Casp1−/−/Casp11−/−, Casp1−/−, Casp1C284A/C284A, and Gsdmd−/− primary BMDMs after transfection of poly(dA:dT). Graphs show mean ± SD. **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001 (unpaired t test). Data and blot are representative of at least three independent experiments.

  • Figure S6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S6.

    Inflammasome activation in Gsdmd−/− results in rapid mitochondrial outer membrane permeabilization. (A) Confocal microscopy images showing MitoTracker Green (Green) and MitoTracker Red (Red) and DIC, 30 and 60 min post-poly(dA:dT) transfection into LPS-primed Gsdmd−/− and Asc−/− iBMDMs. (B, C, D) LDH release and Titer-Glo measurements at 0, 15, 30, and 45 min or as indicated from LPS-primed WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary BMDMs after transfection with poly(dA:dT) (C) or infection with log-phase Salmonella typhimurium at MOI 10 (B, D). Scale bar = 10 μm. Graphs show mean ± SD. Data and blot are representative of at least three independent experiments.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4. Mitochondrial damage is caused by truncated Bid.

    (A) LDH release and Titer-Glo measurements from LPS-primed WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary BMDMs after transfection with poly(dA:dT). (B) Schematic cleavage profile of Bcl-2 family members generated from slice SILAC data. Bubble diameters are proportional to the number of quantified peptide matches, whereas the gradient color represents the H/L ratio, as indicated below. The green bubbles (negative log2H/L) represent protein isoforms reduced in Gsdmd−/− iBMDMs compared with Asc−/− iBMDMs at 3 h post-poly(dA:dT) transfection; red bubbles (positive log2H/L) represent protein isoforms enriched in Gsdmd−/− iBMDMs compared with Asc−/− iBMDMs. (C) Immunoblots showing Bid processing from LPS-primed WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary BMDMs after transfection with poly(dA:dT). (D) LDH release from WT, Asc−/−, Casp1−/−/Casp11−/−, Gsdmd−/−, and Gsdmd−/−/Bid−/− iBMDMs after transfection with poly(dA:dT). Graphs show mean ± SD. *P ≤ 0.05, **P ≤ 0.01, ****P ≤ 0.0001, “ns,” no significance (unpaired t test). Data and blots are representative of at least three independent experiments.

  • Figure S7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S7.

    Gsdmd−/−/Bid−/− cells are resistant to canonical inflammasome activation. (A) Immunoblots showing Bid expression in Gsdmd−/− and Gsdmd−/−/Bid−/− iBMDMs. (B, C) Caspase-3/-7 activity (DEVDase activity) and PI influx in Gsdmd−/− and pool of Gsdmd−/−/Bid−/− clones (n = 5) iBMDMs after transfection with poly(dA:dT). (D) Confocal images of cells of Gsdmd−/− and Gsdmd−/−/Bid−/− iBMDMs after transfection with poly(dA:dT) for 3 h. Insets show membrane ballooning in dying cells. Scale bar = 10 μm. Graphs show mean ± SD. Data and blot are representative of at least three independent experiments.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5. Caspase-1 drives Bid processing during GSDMD-independent secondary necrosis.

    (A) Immunoblots showing caspase-1, caspase-7, caspase-3, caspase-8, and caspase-9 processing in WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary BMDMs after transfection with poly(dA:dT). (B) LDH release from WT, Asc−/−, Casp1−/−/Casp11−/−, Gsdmd−/−, and Gsdmd−/−/Casp8−/− iBMDMs after transfection with poly(dA:dT). (C) Immunoblots showing caspase-3 processing in Gsdmd−/− and Gsdmd−/−/Casp8−/− iBMDMs after transfection with poly(dA:dT). (D) Immunoblots showing Bid cleavage in Gsdmd−/− and Gsdmd−/−/Casp8−/− iBMDMs after transfection with poly(dA:dT). (E) Immunoblots showing Bid cleavage in Gsdmd−/− and Gsdmd−/−/Casp1−/− iBMDMs after transfection with poly(dA:dT). (F) In vitro cleavage assay showing processing of recombinant Bid by recombinant caspase-1. Graphs show mean ± SD. * “ns,” no significance (unpaired t test). Data and blot are representative of at least three independent experiments.

  • Figure S8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S8.

    Caspase-8 is not required for GSDMD-independent secondary necrosis. (A) Immunoblots showing caspase-1, caspase-7, caspase-3, caspase-8, and caspase-9 processing in WT, Asc−/−, Casp1−/−/Casp11−/−, and Gsdmd−/− primary BMDMs after transfection with poly(dA:dT). (B) Immunoblots showing caspase-8 expression in Gsdmd−/− and Gsdmd−/−/Casp8−/− iBMDMs. (C) LDH release in LPS-primed Gsdmd−/− and Gsdmd−/−/Casp8−/− iBMDMs after transfection with poly(dA:dT) in the presence of 100 ng/ml TNF−α, the SMAC mimetic AZD5582 (5 μM), or AZD5582/GSK872. (D) PI influx in Gsdmd−/− and pool of Gsdmd−/−/Casp8−/− clones (n = 3) iBMDMs after transfection with poly(dA:dT). Graphs show mean ± SD. Data and blot are representative of at least three independent experiments.

  • Figure S9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S9.

    SMAC release and initiator caspases-8/-9 are required for GSDMD-independent secondary necrosis. (A) Immunoblots showing Casp-9 expression in Gsdmd−/− and Gsdmd−/−/Casp9−/− iBMDMs. (B) PI uptake of Gsdmd−/− and Gsdmd−/−/Casp9−/− iBMDMs treated with 2 μM ABT737 and 2 μM S63845. (C) PI uptake in LPS-primed and poly(dA:dT)–transfected Gsdmd−/− and pool of Gsdmd−/−/Casp9−/− clones (n = 2) iBMDMs. (D) Immunoblots showing Casp-8 and Casp-9 expression in Gsdmd−/− and Gsdmd−/−/Casp8−/−/Casp9−/− iBMDMs. (E) Immunoblots showing caspase-3 processing in Gsdmd−/− and Gsdmd−/−/Bid−/− iBMDMs after transfection with poly(dA:dT). (F) Immunoblots showing caspase-3 processing in Gsdmd−/− and Gsdmd−/−/Bid−/− iBMDMs after transfection with poly(dA:dT) and treatment with AZD5582. Graphs show mean ± SD. Data and blot are representative of at least three independent experiments.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6. SMAC release and initiator caspases-8/-9 are required for GSDMD-independent secondary necrosis.

    (A) LDH release from WT, Asc−/−, Casp1−/−/Casp11−/−, Gsdmd−/−, and Gsdmd−/−/Casp9−/− iBMDMs after transfection with poly(dA:dT). (B) Immunoblots showing caspase-3 cleavage in Gsdmd−/− and Gsdmd−/−/Casp9−/− iBMDMs after transfection with poly(dA:dT). (C) LDH release from WT, Asc−/−, Casp1−/−/Casp11−/−, Gsdmd−/−, Gsdmd−/−/Casp8−/−, Gsdmd−/−/Casp9−/−, and Gsdmd−/−/Casp8−/−/Casp9−/− iBMDMs after transfection with poly(dA:dT). (D) Immunoblots showing caspase-3 cleavage in Gsdmd−/−, Gsdmd−/−/Casp8−/−, Gsdmd−/−/Casp9−/−, and Gsdmd−/−/Casp8−/−/Casp9−/− iBMDMs after transfection with poly(dA:dT). (E) Immunoblots showing caspase-3 processing from Gsdmd−/− and Gsdmd−/−/Bid−/− iBMDMs after transfection with poly(dA:dT). (F) Schematic summary of the mechanism of caspase-3 cleavage and activation. (G) PI influx in untreated or poly(dA:dT)–transfected Gsdmd−/−/Bid−/− iBMDMs in the presence or absence of the SMAC mimetic AZD5582. Graphs show mean ± SD. *P ≤ 0.05, **P ≤ 0.01 (unpaired t test). Data and blot are representative of at least three independent experiments.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7. Model of cell death in Gsdmd-deficient myeloid cells after activation of caspase-1.

    Model depicting the mechanism of canonical inflammasome activation in WT cells undergoing caspase-1– and GSDMD-dependent pyroptosis and Gsdmd−/− cells undergoing caspase-1–induced GSDMD-independent secondary necrosis.

PreviousNext
Back to top
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Caspase-1 cleaves Bid to release mitochondrial SMAC and drive secondary necrosis in the absence of GSDMD
(Your Name) has sent you a message from Life Science Alliance
(Your Name) thought you would like to see the Life Science Alliance web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
GSDMD-independent cell death requires casp1-driven Bid truncation
Rosalie Heilig, Marisa Dilucca, Dave Boucher, Kaiwen W Chen, Dora Hancz, Benjamin Demarco, Kateryna Shkarina, Petr Broz
Life Science Alliance Apr 2020, 3 (6) e202000735; DOI: 10.26508/lsa.202000735

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
GSDMD-independent cell death requires casp1-driven Bid truncation
Rosalie Heilig, Marisa Dilucca, Dave Boucher, Kaiwen W Chen, Dora Hancz, Benjamin Demarco, Kateryna Shkarina, Petr Broz
Life Science Alliance Apr 2020, 3 (6) e202000735; DOI: 10.26508/lsa.202000735
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
Issue Cover

In this Issue

Volume 3, No. 6
June 2020
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Masthead (PDF)
Advertisement

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgements
    • References
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF

Subjects

  • Immunology
  • Cell Biology

EMBO Press LogoRockefeller University Press LogoCold Spring Harbor Logo

Content

  • Home
  • Newest Articles
  • Current Issue
  • Archive
  • Subject Collections

For Authors

  • Submit a Manuscript
  • Author Guidelines
  • License, copyright, Fee

Other Services

  • Alerts
  • Twitter
  • RSS Feeds

More Information

  • Editors & Staff
  • Reviewer Guidelines
  • Feedback
  • Licensing and Reuse
  • Privacy Policy

ISSN: 2575-1077
© 2022 Life Science Alliance LLC

Life Science Alliance is registered as a trademark in the U.S. Patent and Trade Mark Office and in the European Union Intellectual Property Office.